Company patents

MEDICAROID CORPORATION

MEDICAROID CORPORATION's patent strategy reveals a surprising and significant shift away from its core focus, with its dominant "Medical Diagnostics & Surgery" category, representing 98.4% of its portfolio, experiencing a sharp decline in patenting activity, down 27.6% in 2024, 57.1% in 2025, and 66.7% so far in 2026, alongside a complete cessation of patenting in "Manipulators & Robotics" and "Image Processing" since 2025, indicating a broad re-evaluation of its R&D priorities across multiple technology areas.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

63 US filings (since 2023) · 7 categories · 5 themes

Patents

Showing 1-10 of 142

Page 1 of 15